Altus completes tender offer for MGC shares

Altus Capital Partners has completed its tender offer for all of the outstanding shares of MGC Diagnostics Corporation at $11.03 per share. At the close of the market on December 28, 2017, MGC is expected to stop trading on the NASDAQ. Headquartered in St. Paul, Minnesota, MGC is a provider of cardiorespiratory health solutions.

DealsNorth AmericaUSHealthcareBriefs